AG0065JS

99614-02-5 | 9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-2,3,4,9-tetrahydro-1H-carbazol-4-one

AG0065JS

SDS

COA

Price

$0.00

WARNING This product is not for human or veterinary use.

CAS Number	99614-02-5
Catalog Number	AG0065JS(AGN-PC-0W9MM0)
Chemical Name	9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-2,3,4,9-tetrahydro-1H-carbazol-4-one
IUPAC Name	9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one
InChI	InChI=1S/C18H19N3O/c1-12-19-9-10-21(12)11-13-7-8-16-17(18(13)22)14-5-3-4-6-15(14)20(16)2/h3-6,9-10,13H,7-8,11H2,1-2H3
InChI Key	FELGMEQIXOGIFQ-UHFFFAOYSA-N
MDL Number	MFCD00764297
Molecular Formula	C18H19N3O
Molecular Weight	293.3630
SMILES	O=C1C(CN2C=CN=C2C)CCC(N3C)=C1C4=C3C=CC=C4
Synonyms	Dihydrate, Ondansetron Monohydrochloride, GR 38032F, GR-38032F, GR38032F, Hydrochloride, Ondansetron, Monohydrochloride Dihydrate, Ondansetron, Monohydrochloride, Ondansetron, Ondansetron, Ondansetron Hydrochloride, Ondansetron Monohydrochloride, Ondansetron Monohydrochloride Dihydrate, Ondansetron, (+,-)-Isomer, Ondansetron, (R)-Isomer, Ondansetron, (S)-Isomer, SN 307, SN-307, SN307, Zofran, ondansetron, 99614-02-5, Zofran, Zophren, Zudan, Zofran ODT, 9-Methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-2,3-dihydro-1H-carbazol-4(9H)-one, Zuplenz, ondansetron (Zofran), GR 38032X, GR-38032F, 116002-70-1, BRN 3622981, GR 38032, 9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one, CHEBI:7773, C18H19N3O, SN-307, 1,2,3,9-Tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-4H-carbazol-4-one, 9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-2,3,4,9-tetrahydro-1H-carbazol-4-one, GR38032, NCGC00179341-02, ZOFRAN IN PLASTIC CONTAINER, DSSTox_CID_3393, (RS)-1,2,3,9-Tetrahydro-9-methyl-3-(2-methylimidazol-1-ylmethyl)carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one, 4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-, 9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-1,2,3,9-tetrahydro-4H-carbazol-4-one, 9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one, DSSTox_RID_77011, DSSTox_GSID_23393, Apo-ondansetron, Novo-ondansetron, PHL-ondansetron, PMS-ondansetron, 99614-01-4, Ratio-ondansetron, GR38032F, Sandoz ondansetron, Ondansetron, (+,-)-Isomer, CAS-99614-02-5, Ondansetron Injection, Ondansetron [USAN:INN:BAN], Zofran ODT (TN), Ondansetron (JAN/USP/INN), Ondansetron [USP:INN:BAN], SR-01000763250, ondansetron-zofran, 9-methyl-3-[(2-methylimidazolyl)methyl]-1,2,3,9-tetrahydro-4aH-carbazol-4-one, Ondansetron (base and/or unspecified salts), AC1L1IIM, CHEMBL46, Prestwick0_001058, Prestwick1_001058, Prestwick2_001058, Prestwick3_001058, Odansetron [common misspelling of ondansetron], SCHEMBL4542, TimTec1_001750, Oprea1_435466, Oprea1_852372, BSPBio_001016, CBDivE_008994, MLS006011928, SPBio_002938, BPBio1_001118, GTPL2290, DTXSID8023393, BDBM85330, CTK8G2184, HSDB 8304, HY-B0002B, KS-00000JSZ, FELGMEQIXOGIFQ-UHFFFAOYSA-N, HMS2090H16, HMS3259H08, HMS3371E18, ACT02589, BCP28911, Tox21_113048, BBL010304, CAS_68647, MFCD00833882, NSC_68647, QC-660, s1996, SBB066158, STK370548, AKOS000599484, AKOS016340526, Tox21_113048_1, ACN-049703, AN-6592, BCP9001025, CS-2393, DB00904, GR-C507/75, KS-5227, MCULE-9438746800, NC00706, VA11441, 1,2,3,4-Tetrahydro-9-methyl-3-(2-methyl-1H-imidazol-1-ylmethyl)carbazol-4-one, 9-Methyl-3-(2-methyl-imidazol-1-ylmethyl)-1,2,3,9-tetrahydro-carbazol-4-one, NCGC00179341-04, NCGC00179341-07, AC-28927, AK-29654, BAS 00717177, BC220610, BR-29654, CPD001307702, GR-38032, I544, LS-51878, NCI60_022780, SAM002589958, SC-07554, SMR001307702, ST077669, GR-38032F/GR-38032, AB0013753, AB2000413, LS-172305, ST2412612, TL8006071, AB00373674, FT-0631004, 39O049, C07325, D00456, S-2116, AB00373674-15, AB00373674-17, AB00373674_18, AB00373674_19, L000456, I06-0687, I06-1329, SR-01000763250-4, BRD-A19736161-001-01-8, BRD-A19736161-003-03-0, Z1741971217, 1,2,3,9,-Tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H- carbazol-4-one, 1,2,3,9-Tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1yl)methyl]-4H-carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazole-1 -yl)methyl]-4H-carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazole-1-yl)methyl]-4H-carbazol-4-one, 9-Methyl-3- (2-methyl-imidazol-1ylmethyl)-1,2,3,9-tetrahydro-carbazol-4-one, Ondansetron?, Ondansetron Base, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HCl, Zofran (TN), DESMETHYLONDANSETRON, UNII-4AF302ESOS, UNII-NMH84OZK2B, Hydrochloride, Ondansetron, Ondansetron, (R)-Isomer, Ondansetron, (S)-Isomer, D0K7WK, Ondansetron Monohydrochloride, 4AF302ESOS, Ondansetron hydrochloride dihydrate, Monohydrochloride, Ondansetron, ZOFRAN PRESERVATIVE FREE, C18H19N3O.ClH.2H2O, CID4595, GR 38032F, SN307, C18-H19-N3-O, SN 307, Ondansetron hydrochloride [USAN:JAN], Ondansetron Monohydrochloride Dihydrate, CS-O-00286, Dihydrate, Ondansetron Monohydrochloride, Monohydrochloride Dihydrate, Ondansetron, C18-H19-N3-O.Cl-H.2H2-O, Ondansetron hydrochloride [USAN:USP:JAN], 1530B, A5166, D017294, 103639-04-9, (3S)-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-2,3,4,9-tetrahydro-1H-carbazol-4-one, Ondansetron, 98%, a serotonin 5-HT3 receptor antagonist - 1G 1g, 99614-58-1, (3S)-9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one, 4H-Carbazol-4-one, 1,2,3,9-tetrahidro-9-metil-3-[(2-metil-1H-imidazol-1-il) metil]-, (+-)-2,3-Dihydro-9-methyl-3-((2-methylimidazol-1-yl)methyl)carbazol-4(1H)-one monohydrochloride dihydrate,

Complexity	440
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	293.153g/mol
Formal Charge	0
Heavy Atom Count	22
Hydrogen Bond Acceptor Count	2
Hydrogen Bond Donor Count	0
Isotope Atom Count	0
Molecular Weight	293.37g/mol
Monoisotopic Mass	293.153g/mol
Rotatable Bond Count	2
Topological Polar Surface Area	39.8A^2
Undefined Atom Stereocenter Count	1
Undefined Bond Stereocenter Count	0
XLogP3	2.3

GHS Hazard and Precautionary Statements

Symbol:
Hazard statements	H301
Precuationary statements	P301+P310
Siginal words

Certificate of Analysis

Lot Number